PolyRemedy Seals $20M Series C
Delphi Ventures led a $20 million Series C round for PolyRemedy, a maker of personalized wound care systems. The round included all previous investors: Advanced Technology Ventures, Flybridge Capital Partners, and MedVenture Associates. In addition to the new funding, PolyRemedy also announced that it had added Cameron McKennitt as chief commercial officer. The money will help Boston and Mountain View, Calif.-based PolyRemedy commercialize its wound care system, designed to help people manage chronic wounds in home health care and other settings.
7 June 2011•2 mins read
